WO2005030064A1 - A device for staunching postpartum haemorrhage - Google Patents

A device for staunching postpartum haemorrhage Download PDF

Info

Publication number
WO2005030064A1
WO2005030064A1 PCT/IE2004/000133 IE2004000133W WO2005030064A1 WO 2005030064 A1 WO2005030064 A1 WO 2005030064A1 IE 2004000133 W IE2004000133 W IE 2004000133W WO 2005030064 A1 WO2005030064 A1 WO 2005030064A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
internal balloon
indicator
internal
uterus
Prior art date
Application number
PCT/IE2004/000133
Other languages
French (fr)
Inventor
Paul Anthony Slattery
Gerard Burke
Original Assignee
Frontline Medical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frontline Medical Limited filed Critical Frontline Medical Limited
Publication of WO2005030064A1 publication Critical patent/WO2005030064A1/en
Priority to US11/391,475 priority Critical patent/US20060173486A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00557Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable

Definitions

  • the invention relates to a device for use in cases of obstetric haemorrhage following childbirth, known as postpartum haemorrhage (PPH).
  • PPH postpartum haemorrhage
  • PPH Postpartum haemorrhage
  • Towel packing is the only method of treatment currently in use in the developing world. Towels or other bulky absorbent materials are used to pack the uterus in the hope of applying enough pressure to stop the bleeding. This method is usually ineffective and has major problems associated with unretrieved packing and potential infection.
  • a device for staunching postpartum haemorrhage comprising: - an internal balloon for insertion into a uterus; the internal balloon being inflatable to engage the wall of a uterus; a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid communication with an inflation source; the internal balloon being attached to the tubular conduit at a single attachment region to facilitate unconstrained inflation of the internal balloon; and a first indicator for indicating when the internal balloon has engaged the wall of a uterus.
  • the device comprises a second indicator for indicating subsequent contraction of a uterus.
  • the first indicator and the second indicator are preferably provided by a single indicator device.
  • the tubular conduit defines a longitudinal axis
  • the internal balloon is inflatable in a direction parallel to the tubular conduit longitudinal axis.
  • the internal balloon defines three mutually perpendicular co-ordinate axes, and the internal balloon is inflatable in directions parallel to all three co-ordinate axes.
  • the internal balloon comprises an inlet, and the inlet of the internal balloon is attached to the single attachment region of the tubular conduit.
  • the internal balloon comprises a continuous balloon wall with a single opening in the balloon wall, the single opening providing the inlet.
  • an outer surface of the internal balloon is substantially smooth.
  • the indicator is connected in fluid communication with the tubular conduit.
  • the tubular conduit comprises an indicator port for connecting the indicator in fluid communication with the tubular conduit.
  • the device comprises external valves means intermediate the tubular conduit and the indicator.
  • the indicator may be inflatable.
  • the indicator comprises an external balloon.
  • the internal balloon and the external balloon may be configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
  • the defined pressure is less than or equal to mean arterial pressure.
  • the dimensions of the internal balloon and the dimensions of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
  • - ri radius of the internal balloon when in a static uninflated state.
  • r 2 radius of the external balloon when in a static uninflated state
  • ti wall thickness of the internal balloon when in a static uninflated state.
  • t 2 wall thickness of the external balloon when in a static uninflated state.
  • the volume of the internal balloon when in a static uninflated state is preferably substantially larger than the volume of the external balloon when in a static uninflated state.
  • the ratio of the volume of the internal balloon when in a static uninflated state to the volume of the external balloon when in a static uninflated state may be at least 10:1.
  • the ratio may be at least 15:1.
  • the ratio is approximately 17:1.
  • the surface area of the internal balloon when in a static uninflated state is preferably substantially larger than the surface area of the external balloon when in a static uninflated state.
  • the ratio of the surface area of the internal balloon when in a static uninflated state to the surface area of the external balloon when in a static uninflated state may be at least 5:1. The ratio is approximately 7:1.
  • the material properties of the internal balloon and the material properties of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
  • E 2 modulus of elasticity of the external balloon
  • the device comprises a connector for attaching the internal balloon to the tubular conduit.
  • the connector has a proximal region attached to an outer surface of the tubular conduit, and a distal region attached to an outer surface of the internal balloon.
  • the distal region extends substantially tangentially around at least part of the outer surface of the internal balloon.
  • the connector may taper outwardly from a proximal end of the connector to a distal end of the connector.
  • the invention provides a method of staunching postpartum haemorrhage comprising the steps of: - providing a device comprising an internal balloon, a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid connection with an inflation source, and a first indicator; inserting the internal balloon into a uterine cavity; inflating the internal balloon until the internal balloon engages the wall of the uterus; and monitoring the first indicator to determine when the internal balloon has engaged the wall of the uterus.
  • engagement of the internal balloon with the wall of the uterus causes the first indicator to inflate.
  • the first indicator is connected in fluid communication with the tubular conduit.
  • the device may comprise a second indicator, and the method may comprise the step of monitoring the second indicator to determine subsequent contraction of the uterus. Ideally subsequent contraction of the uterus causes the second indicator to inflate. Most preferably the second indicator is connected in fluid communication with the tubular conduit. The first indicator and the second indicator may be provided by a single indicator device.
  • the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, stopping inflation of the internal balloon.
  • the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus.
  • the method comprises the step of disconnecting the indicator from the tubular conduit before further inflating the internal balloon.
  • the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the indicator.
  • the method comprises the step of at least partially deflating the indicator to further inflate the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus.
  • the indicator is at least partially deflated by squeezing the indicator.
  • the postpartum uterus is a large cavity. Because the internal balloon is unconstrained upon inflation, this enables the internal balloon to effectively and quickly expand to fill the volume of the uterus, which can be over 2 litres. When the volume has been filled, the internal balloon engages the wall of the uterus to achieve haemostasis.
  • the longitudinal inflation is especially important in ensuring that the internal balloon fills the volume of the postpartum uterus to engage the wall of the uterus and achieve haemostasis.
  • the invention provides a large haemostatic fluid-filled balloon to temporarily pack the uterus and staunch bleeding.
  • the balloon works in two ways. Firstly, direct compression is applied to the placental bed, thus reducing bleeding. Secondly, by stretching the uterine muscle, a reflex contraction may occur encouraging the natural muscle tourniquet effect
  • the invention provides a large obstetric balloon that can be safely employed as an interim measure before undertaking hysterectomy and furthermore may be usefully employed for transport of bleeding patients to a centre where they can undergo appropriate treatment.
  • the balloon can easily be fitted and operated by a paramedical person.
  • the device provides an indication to the user as to whether or not the balloon is sufficiently expanded and whether or not uterine contraction is occurring.
  • the device can be used to apply rhythmic stimulation of the uterine muscle, if appropriate.
  • Fig. 1 is a perspective view of a device for staunching postpartum haemorrhage according to the invention
  • Fig. 1(a) is an enlarged, cross-sectional, plan view of a part of the device of Fig. 1;
  • Figs. 2 to 6 illustrate various steps in the use of the device.
  • the device 1 for staunching postpartum haemorrhage of the uterus U (Fig. 2).
  • the device 1 comprises an inflatable internal balloon 2 having an inlet connected by a fitting 3 over a distal end 4 of a tubular conduit 5.
  • the tubular conduit 5 has a proximal end 6 for connection to an inflation source, preferably a hand-operated pump 7 or a syringe for manually inflating the internal balloon 2.
  • a non-return valve 8 is fitted in the conduit 5 at the proximal end 6.
  • the device 1 has an integral indicator, in this case in the form of an inflatable external balloon 10 for indicating when the surface of the internal balloon 2 has engaged with the wall of the uterus TJ.
  • the external balloon 10 also acts as an indicator to indicate subsequent contraction of the uterus TJ.
  • the internal balloon inlet is attached to the tubular conduit 5 at a single attachment region.
  • This attachment arrangement facilitates unconstrained inflation of the internal balloon 2.
  • the balloon 2 may inflate in all three co-ordinate directions. It is especially important that the balloon 2 can inflate in the direction parallel to the longitudinal axis of the tubular conduit 5 so that the internal balloon 2 can effectively fill the uterine cavity.
  • the conduit 5 is split adjacent the proximal end 6 thereof and a tee-piece 12 is inserted.
  • the tee-piece 12 has a spur line 13 fitted with a valve 14.
  • the external balloon 10 is in fluid communication with the internal balloon 2.
  • the large main or internal balloon 2 is used to directly compress the vascular bed of the uterus TJ and completely fill the void of the uterus TJ and thus achieve haemostasis.
  • the indicator balloon 10 indicates when the surface of the main balloon 2 has engaged the wall of the uterus TJ.
  • the internal balloon 2 has a continuous, smooth balloon wall with a single opening in the balloon wall which acts as the inlet to the balloon 2. This arrangement ensures that the engagement of the balloon 2 with the wall of the uterus U occurs with the minimum of discomfort / trauma. In particular there are no sharp or protruding parts of the balloon 2 which could act to snag or pierce the wall of the uterus U.
  • the internal balloon 2 inflates , while the external balloon 10 resists inflation.
  • the dimensions of the balloons 2, 10 may be configured to achieve this effect.
  • the material properties may be configured to achieve this effect.
  • the modulus of elasticity of the internal balloon 2 may be lower than the modulus of the elasticity of the external balloon 10.
  • the balloons 2, 10 are fluidly connected and thus sense the same internal pressure. However, the volume of the internal balloon 2 is several times larger than that of the external balloon 10. Both balloons 2, 10 may be of similar material with similar elastic properties.
  • the ratio of the balloon static sizes (uninflated) determines the principle of operation of the device. These size ratios may be specifically set to determine the contact pressure that the internal balloon 2 exerts on the wall of the uterus TJ. In one case the device may deliver contact pressure on the wall of the uterus U equivalent to mean arterial pressure.
  • the wall thicknesses of the two balloons 2, 10 are identical in this case, the pressure in this fluidically connected system is the same everywhere in the system. Therefore, when the system is pressurised in free space (internal balloon 2 inside the uterus U but not in contact with the wall) it can be seen that the stress exerted on the internal balloon 2 by the fluid is greater than that exerted on the external balloon 10 due to the far greater radius of the internal balloon 2. This forces the internal balloon 2 to expand, ⁇ vhile the external balloon 10 remains unexpanded.
  • the uterus U On intimate contact with the wall of the uterus U, it is now the uterus U which forms a bouding surface, itself an approximately spherical vessel, with a far more substantial wall thickness.
  • the stress induced in the wall of the uterus TJ is lower than that in the external balloon 10 and further inflation will cause the external balloon 10 to expand and thus indicate to the clinician contact between the internal balloon 2 and the wall of the uterus TJ.
  • the system of the internal balloon 2, the external balloon 10 and the uterus U now enters a state of equilibrium. The system may then be filled with more air, expanding the external sensing balloon 10.
  • the external balloon 10 may then be squeezed manually to change the contact pressure of the internal balloon 2, thus stimulating the uterine muscle to contract.
  • An important feature of the device 1 is the difference in size of the balloons 2, 10.
  • the internal balloon 2 is significantly larger than the external balloon 10.
  • the volumetric ratio of the balloons 2, 10 in this system is about 17:1, and the surface area ratio is about 7:1.
  • the volumetric ratio and the surface area ratio increase and can go to 50:1 or greater.
  • both the internal balloon 2 and the external balloon 10 are formed from silicone by dip moulding.
  • the connector fitting 3 has a proximal end 20 attached to the outer surface of the tubular conduit 5 and a distal end 21 attached to the outer surface of the balloon 2.
  • the connector fitting 3 tapers outwardly from the proximal end 20 to the distal end 21 in two funnel-type arrangements.
  • the distal end 21 extends tangentially around a part of the balloon 2. It has been found that this type of attachment arrangement results in a more secure attachment. In particular this attachment arrangement is better able to withstand peel stresses than conventional attachment arrangements.
  • Fig. 2 illustrates a distended atonic uterus TJ, postpartum.
  • Fig. 3 illustrates the main internal balloon 2 inserted via the vagina and cervix into the uterus TJ.
  • the internal balloon 2 is shown being inflated with fluid via a hand pump 7 or syringe.
  • the valve 14 is open to the over pressure external balloon 10 which senses the same pressure as the internal balloon 2.
  • any suitable fluid may be employed for inflation of the internal balloon 2, such as air, water, saline solution, C0 2 .
  • the internal balloon 2 inflates until the outer surface of the internal balloon 2 engages the wall of the uterus TJ (Fig. 5).
  • the internal balloon 2 When free and unengaged, the internal balloon 2 is generally spherical 2. Upon engagement with the wall of the uterus TJ, some conforming of the shape of the internal balloon 2 and the shape of the uterus TJ occurs until both the internal balloon 2 and the uterus TJ have conformed to an equilibrium shape. Although the equilibrium shape is illustrated in Fig. 5 as being generally spherical, it will be appreciated that the internal balloon 2 and the uterus TJ may conform to other non-uniform equilibrium shapes depending on the particular circumstances.
  • the dimensions and material properties of the balloons 2, 10 are chosen to ensure that the external balloon 10 will begin to inflate, when the fluid pressure within the balloons 2, 10 reaches mean arterial pressure, in this case set to a pressure of approximately 100 cm of water.
  • the dimensions and material properties of the balloons 2, 10 may be varied as desired to achieve inflation of the external balloon 10 at any desired pressure.
  • the mean arterial pressure may be higher or lower than 100 cm of water depending on the animal physiology.
  • the dimensions and material properties of the balloons 2, 10 could be configured to achieve inflation of the external balloon 10 at a pressure other than mean arterial pressure. Depending on the particular medical indications, it may be desirable to operate with a pressure higher or lower than the mean arterial pressure in the balloons 2, 10.
  • the operator may then elect to: -
  • valve 14 open and introduce a volume of fluid so as to expand the over pressure external balloon 10.
  • the expanded over pressure external balloon 10 may be squeezed manually to vary the contact pressure of the main internal balloon 2. This variation in contact pressure may aid the initiation of contraction of the uterine muscle.
  • the internal balloon 2 may be left 'in situ' in the uterus TJ to maintain haemostasis. It is possible to leave the internal balloon 2 inserted in the uterus TJ for up to 30 hours, if necessary.
  • the over pressure external balloon 10 will expand, indicating that contraction is occurring. Fluid flow may then be varied via the valve 14 keeping the over pressure external balloon 10 small in size and maintaining engagement between the internal balloon 2 and the wall of the uterus TJ.
  • the system of the internal balloon 2 connected in fluid communication with the external balloon 10 provides a self -regulating safety mechanism.
  • the external balloon 10 may expand and thus enable the internal balloon 2 to contract to facilitate the contracting of the uterus TJ.
  • the uterus TJ may at least partially relax again. If this should occur, the external balloon 10 may contract and thus enable the internal balloon 2 to expand to maintain engagement with the wall of the uterus TJ and maintain haemostasis.
  • the device 1 as described above was inserted and inflated quickly using saline to a volume of 200cc.
  • the internal balloon 2 was checked for position and fit under ultrasound guidance. There was an immediate and dramatic reduction of bleeding and over the next two hours, the clinician was able to gradually deflate the internal balloon 2 and remove it. There was only minimal blood loss following this.
  • the internal balloon 2 is inserted into a blind cavity. In a paramedical situation there is not way to determine whether or not a balloon on its own is engaged with the wall of the uterus TJ with any degree of certainty.
  • the external balloon 10 functions as a detector / regulator of this contact pressure.
  • the device 1 of the invention can be used for atonic uterus and thus it may prove to be a worthwhile and lifesaving device in countries where there is a high incidence of death from primary postpartum haemorrhage and where access to surgical facilities and pharmacology is poor.
  • the device 1 is simple and mobile, and can be used in the field.
  • the device 1 is light and compact and requires no specialised equipment for operation.
  • the device 1 does not require an electrical power source to operate.
  • the device 1 is particularly suitable for paramedical applications.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)

Abstract

A device (1) for staunching postpartum haemorrhage of the uterus (U). The device (1) comprises an inflatable internal balloon (2) having an inlet connected by a fitting (3) over a distal end (4) of a tubular conduit (5). The tubular conduit (5) has a proximal end (6) for connection to an inflation source for manually inflating the internal balloon (2). A non-return valve (8) is fitted in the conduit (5) at the proximal end (6). The device (1) has an inflatable external balloon (10) for indicating when the surface of the internal balloon (2) has engaged with the wall of the uterus (U). The external balloon (10) also acts as an indicator to indicate subsequent contraction of the uterus (U).

Description

"A device for staunching postpartum haemorrhage"
Introduction
The invention relates to a device for use in cases of obstetric haemorrhage following childbirth, known as postpartum haemorrhage (PPH).
Postpartum haemorrhage (PPH) is a common condition affecting up to 5% of births. It is serious in that it is estimated that at least 150,000 women die annually around the world from this condition and the actual number may be far higher.
Immediately following childbirth the uterus begins to contract. This contraction gives rise to what is known as the tourniquet effect, whereby the haemorrhaging uterine vasculature is constricted by the tightening muscle fibres and haemostasis is achieved. In some women, roughly 5%, this mechanism is compromised and following childbirth the uterus is atonal and unable to contract. Current treatment involves the use of pharmacological agents such as Oxytocin and Prostaglandins. Where these prove to be unsuccessful, hysterectomy may be the only course of action. Hysterectomy is only available in well-staffed and equipped maternity units. Before proceeding with hysterectomy, packing of the uterus with gauze has been attempted but is not now considered effective. The procedure of packing and unpacking the uterus is difficult at best and any packing that is unretrieved leads to serious complications. Furthermore, the gauze becomes saturated with blood and blood loss may be more difficult to detect. There are also concerns about infection.
In developing world situations where access to facilities and pharmacology is poor, the outcome is usually far more serious in that death results. On average, a mother will die within 2 hours of the onset of PPH. Survivors of PPH in these circumstances often face severe lifetime problems of anaemia and recurrent infections. Towel packing is the only method of treatment currently in use in the developing world. Towels or other bulky absorbent materials are used to pack the uterus in the hope of applying enough pressure to stop the bleeding. This method is usually ineffective and has major problems associated with unretrieved packing and potential infection.
There is therefore a need for a device which will address these serious clinical problems in a cost efficient manner.
Statements of Invention
According to the invention there is provided a device for staunching postpartum haemorrhage comprising: - an internal balloon for insertion into a uterus; the internal balloon being inflatable to engage the wall of a uterus; a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid communication with an inflation source; the internal balloon being attached to the tubular conduit at a single attachment region to facilitate unconstrained inflation of the internal balloon; and a first indicator for indicating when the internal balloon has engaged the wall of a uterus.
In one embodiment the device comprises a second indicator for indicating subsequent contraction of a uterus. The first indicator and the second indicator are preferably provided by a single indicator device.
In one case the tubular conduit defines a longitudinal axis, and the internal balloon is inflatable in a direction parallel to the tubular conduit longitudinal axis. Preferably the internal balloon defines three mutually perpendicular co-ordinate axes, and the internal balloon is inflatable in directions parallel to all three co-ordinate axes.
In another case the internal balloon comprises an inlet, and the inlet of the internal balloon is attached to the single attachment region of the tubular conduit. Preferably the internal balloon comprises a continuous balloon wall with a single opening in the balloon wall, the single opening providing the inlet. Ideally an outer surface of the internal balloon is substantially smooth.
In a preferred embodiment the indicator is connected in fluid communication with the tubular conduit. Ideally the tubular conduit comprises an indicator port for connecting the indicator in fluid communication with the tubular conduit. Most preferably the device comprises external valves means intermediate the tubular conduit and the indicator. The indicator may be inflatable. Preferably the indicator comprises an external balloon.
The internal balloon and the external balloon may be configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon. Preferably the defined pressure is less than or equal to mean arterial pressure.
In one case the dimensions of the internal balloon and the dimensions of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
Preferably: -
Figure imgf000005_0001
where: - ri = radius of the internal balloon when in a static uninflated state. r2 = radius of the external balloon when in a static uninflated state, ti = wall thickness of the internal balloon when in a static uninflated state. t2 = wall thickness of the external balloon when in a static uninflated state.
The ratio of rι/tι : r2/t2
may be at least 2:1.
The ratio of rι tι : r2/t2
is preferably approximately 2.5:1.
The volume of the internal balloon when in a static uninflated state is preferably substantially larger than the volume of the external balloon when in a static uninflated state. The ratio of the volume of the internal balloon when in a static uninflated state to the volume of the external balloon when in a static uninflated state may be at least 10:1. The ratio may be at least 15:1. The ratio is approximately 17:1.
The surface area of the internal balloon when in a static uninflated state is preferably substantially larger than the surface area of the external balloon when in a static uninflated state. The ratio of the surface area of the internal balloon when in a static uninflated state to the surface area of the external balloon when in a static uninflated state may be at least 5:1. The ratio is approximately 7:1. In another case the material properties of the internal balloon and the material properties of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
Preferably: -
where: - Ei = modulus of elasticity of the internal balloon;
E2 = modulus of elasticity of the external balloon;
In another embodiment the device comprises a connector for attaching the internal balloon to the tubular conduit. Preferably the connector has a proximal region attached to an outer surface of the tubular conduit, and a distal region attached to an outer surface of the internal balloon. Ideally the distal region extends substantially tangentially around at least part of the outer surface of the internal balloon. The connector may taper outwardly from a proximal end of the connector to a distal end of the connector.
In another aspect the invention provides a method of staunching postpartum haemorrhage comprising the steps of: - providing a device comprising an internal balloon, a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid connection with an inflation source, and a first indicator; inserting the internal balloon into a uterine cavity; inflating the internal balloon until the internal balloon engages the wall of the uterus; and monitoring the first indicator to determine when the internal balloon has engaged the wall of the uterus.
In one embodiment engagement of the internal balloon with the wall of the uterus causes the first indicator to inflate. Preferably the first indicator is connected in fluid communication with the tubular conduit.
The device may comprise a second indicator, and the method may comprise the step of monitoring the second indicator to determine subsequent contraction of the uterus. Ideally subsequent contraction of the uterus causes the second indicator to inflate. Most preferably the second indicator is connected in fluid communication with the tubular conduit. The first indicator and the second indicator may be provided by a single indicator device.
In one case the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, stopping inflation of the internal balloon.
In another case the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus. Preferably the method comprises the step of disconnecting the indicator from the tubular conduit before further inflating the internal balloon.
In a further case the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the indicator. Preferably the method comprises the step of at least partially deflating the indicator to further inflate the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus. Ideally the indicator is at least partially deflated by squeezing the indicator.
The postpartum uterus is a large cavity. Because the internal balloon is unconstrained upon inflation, this enables the internal balloon to effectively and quickly expand to fill the volume of the uterus, which can be over 2 litres. When the volume has been filled, the internal balloon engages the wall of the uterus to achieve haemostasis.
The longitudinal inflation is especially important in ensuring that the internal balloon fills the volume of the postpartum uterus to engage the wall of the uterus and achieve haemostasis.
The invention provides a large haemostatic fluid-filled balloon to temporarily pack the uterus and staunch bleeding. The balloon works in two ways. Firstly, direct compression is applied to the placental bed, thus reducing bleeding. Secondly, by stretching the uterine muscle, a reflex contraction may occur encouraging the natural muscle tourniquet effect
The invention provides a large obstetric balloon that can be safely employed as an interim measure before undertaking hysterectomy and furthermore may be usefully employed for transport of bleeding patients to a centre where they can undergo appropriate treatment. The balloon can easily be fitted and operated by a paramedical person.
The device provides an indication to the user as to whether or not the balloon is sufficiently expanded and whether or not uterine contraction is occurring. The device can be used to apply rhythmic stimulation of the uterine muscle, if appropriate. Brief Description of the Drawings
The invention will be more clearly understood from the following description of an embodiment thereof, given by way of example only, with reference to the accompanying drawings, in which: -
Fig. 1 is a perspective view of a device for staunching postpartum haemorrhage according to the invention; Fig. 1(a) is an enlarged, cross-sectional, plan view of a part of the device of Fig. 1; and
Figs. 2 to 6 illustrate various steps in the use of the device.
Detailed Description
Referring to the drawings there is illustrated a device 1 for staunching postpartum haemorrhage of the uterus U (Fig. 2). The device 1 comprises an inflatable internal balloon 2 having an inlet connected by a fitting 3 over a distal end 4 of a tubular conduit 5. The tubular conduit 5 has a proximal end 6 for connection to an inflation source, preferably a hand-operated pump 7 or a syringe for manually inflating the internal balloon 2. A non-return valve 8 is fitted in the conduit 5 at the proximal end 6. The device 1 has an integral indicator, in this case in the form of an inflatable external balloon 10 for indicating when the surface of the internal balloon 2 has engaged with the wall of the uterus TJ. The external balloon 10 also acts as an indicator to indicate subsequent contraction of the uterus TJ.
The internal balloon inlet is attached to the tubular conduit 5 at a single attachment region. This attachment arrangement facilitates unconstrained inflation of the internal balloon 2. In particular the balloon 2 may inflate in all three co-ordinate directions. It is especially important that the balloon 2 can inflate in the direction parallel to the longitudinal axis of the tubular conduit 5 so that the internal balloon 2 can effectively fill the uterine cavity.
The conduit 5 is split adjacent the proximal end 6 thereof and a tee-piece 12 is inserted. The tee-piece 12 has a spur line 13 fitted with a valve 14. On opening of the valve 14, the external balloon 10 is in fluid communication with the internal balloon 2.
The large main or internal balloon 2 is used to directly compress the vascular bed of the uterus TJ and completely fill the void of the uterus TJ and thus achieve haemostasis.
The indicator balloon 10 indicates when the surface of the main balloon 2 has engaged the wall of the uterus TJ.
The internal balloon 2 has a continuous, smooth balloon wall with a single opening in the balloon wall which acts as the inlet to the balloon 2. This arrangement ensures that the engagement of the balloon 2 with the wall of the uterus U occurs with the minimum of discomfort / trauma. In particular there are no sharp or protruding parts of the balloon 2 which could act to snag or pierce the wall of the uterus U.
In this system, up to a certain fluid pressure within the balloons 2, 10, which is the mean arterial pressure in this case, the internal balloon 2 inflates , while the external balloon 10 resists inflation. The dimensions of the balloons 2, 10 may be configured to achieve this effect. Alternatively the material properties may be configured to achieve this effect. For example the modulus of elasticity of the internal balloon 2 may be lower than the modulus of the elasticity of the external balloon 10.
The balloons 2, 10 are fluidly connected and thus sense the same internal pressure. However, the volume of the internal balloon 2 is several times larger than that of the external balloon 10. Both balloons 2, 10 may be of similar material with similar elastic properties. The ratio of the balloon static sizes (uninflated) determines the principle of operation of the device. These size ratios may be specifically set to determine the contact pressure that the internal balloon 2 exerts on the wall of the uterus TJ. In one case the device may deliver contact pressure on the wall of the uterus U equivalent to mean arterial pressure.
Principle of Operation
Stress in a thin-walled spherical vessel is given by the following relationship: cr = Pr/2t
where P = pressure, r = radius of the vessel, t = wall thickness of the vessel.
The wall thicknesses of the two balloons 2, 10 are identical in this case, the pressure in this fluidically connected system is the same everywhere in the system. Therefore, when the system is pressurised in free space (internal balloon 2 inside the uterus U but not in contact with the wall) it can be seen that the stress exerted on the internal balloon 2 by the fluid is greater than that exerted on the external balloon 10 due to the far greater radius of the internal balloon 2. This forces the internal balloon 2 to expand, Λvhile the external balloon 10 remains unexpanded.
On intimate contact with the wall of the uterus U, it is now the uterus U which forms a bouding surface, itself an approximately spherical vessel, with a far more substantial wall thickness. The stress induced in the wall of the uterus TJ is lower than that in the external balloon 10 and further inflation will cause the external balloon 10 to expand and thus indicate to the clinician contact between the internal balloon 2 and the wall of the uterus TJ. The system of the internal balloon 2, the external balloon 10 and the uterus U now enters a state of equilibrium. The system may then be filled with more air, expanding the external sensing balloon 10. The external balloon 10 may then be squeezed manually to change the contact pressure of the internal balloon 2, thus stimulating the uterine muscle to contract.
An important feature of the device 1 is the difference in size of the balloons 2, 10.
The internal balloon 2 is significantly larger than the external balloon 10. The volumetric ratio of the balloons 2, 10 in this system is about 17:1, and the surface area ratio is about 7:1.
As the internal balloon 2 is expanded, the volumetric ratio and the surface area ratio increase and can go to 50:1 or greater.
In this case both the internal balloon 2 and the external balloon 10 are formed from silicone by dip moulding.
As illustrated in Fig. 1(a), the connector fitting 3 has a proximal end 20 attached to the outer surface of the tubular conduit 5 and a distal end 21 attached to the outer surface of the balloon 2. The connector fitting 3 tapers outwardly from the proximal end 20 to the distal end 21 in two funnel-type arrangements. The distal end 21 extends tangentially around a part of the balloon 2. It has been found that this type of attachment arrangement results in a more secure attachment. In particular this attachment arrangement is better able to withstand peel stresses than conventional attachment arrangements.
Fig. 2 illustrates a distended atonic uterus TJ, postpartum.
Fig. 3 illustrates the main internal balloon 2 inserted via the vagina and cervix into the uterus TJ. In Fig. 4 the internal balloon 2 is shown being inflated with fluid via a hand pump 7 or syringe. The valve 14 is open to the over pressure external balloon 10 which senses the same pressure as the internal balloon 2.
It will be appreciated that any suitable fluid may be employed for inflation of the internal balloon 2, such as air, water, saline solution, C02.
The internal balloon 2 inflates until the outer surface of the internal balloon 2 engages the wall of the uterus TJ (Fig. 5).
When free and unengaged, the internal balloon 2 is generally spherical 2. Upon engagement with the wall of the uterus TJ, some conforming of the shape of the internal balloon 2 and the shape of the uterus TJ occurs until both the internal balloon 2 and the uterus TJ have conformed to an equilibrium shape. Although the equilibrium shape is illustrated in Fig. 5 as being generally spherical, it will be appreciated that the internal balloon 2 and the uterus TJ may conform to other non-uniform equilibrium shapes depending on the particular circumstances.
As illustrated in Fig. 5, when the surface of the internal balloon 2 becomes fully engaged with the wall of the uterus TJ, pressure will rise as more fluid is pumped in, due to the force exerted on the internal balloon 2 by the uterine muscle. The over pressure external balloon 10 will now begin to expand, indicating to the operator that engagement between the internal balloon 2 and the wall of the uterus TJ has occurred.
The dimensions and material properties of the balloons 2, 10 are chosen to ensure that the external balloon 10 will begin to inflate, when the fluid pressure within the balloons 2, 10 reaches mean arterial pressure, in this case set to a pressure of approximately 100 cm of water.
It will be appreciated that the dimensions and material properties of the balloons 2, 10 may be varied as desired to achieve inflation of the external balloon 10 at any desired pressure. For example, if the device of the invention was applied in veterinary applications, the mean arterial pressure may be higher or lower than 100 cm of water depending on the animal physiology.
It would also be possible to configure the dimensions and material properties of the balloons 2, 10 to achieve inflation of the external balloon 10 at a pressure other than mean arterial pressure. Depending on the particular medical indications, it may be desirable to operate with a pressure higher or lower than the mean arterial pressure in the balloons 2, 10.
The operator may then elect to: -
1. Cease inflation. 2. Shut off the valve 14, thus isolating the over pressure external balloon 10 and add a measured volume of fluid to the main internal balloon 2 to boost the contact pressure between the main internal balloon 2 and the uterus wall.
3. Leave the valve 14 open and introduce a volume of fluid so as to expand the over pressure external balloon 10. The expanded over pressure external balloon 10 may be squeezed manually to vary the contact pressure of the main internal balloon 2. This variation in contact pressure may aid the initiation of contraction of the uterine muscle.
The internal balloon 2 may be left 'in situ' in the uterus TJ to maintain haemostasis. It is possible to leave the internal balloon 2 inserted in the uterus TJ for up to 30 hours, if necessary.
As uterine contraction begins, the over pressure external balloon 10 will expand, indicating that contraction is occurring. Fluid flow may then be varied via the valve 14 keeping the over pressure external balloon 10 small in size and maintaining engagement between the internal balloon 2 and the wall of the uterus TJ.
The system of the internal balloon 2 connected in fluid communication with the external balloon 10 provides a self -regulating safety mechanism. In particular as the uterus U begins to contract, the external balloon 10 may expand and thus enable the internal balloon 2 to contract to facilitate the contracting of the uterus TJ. In some cases the uterus TJ may at least partially relax again. If this should occur, the external balloon 10 may contract and thus enable the internal balloon 2 to expand to maintain engagement with the wall of the uterus TJ and maintain haemostasis.
Example
A patient presented seven days after a normal delivery with heavy PV bleeding. At examination under anaesthesia, the patient had a retained placental cotyledon and following removal of this, the uterus bled very heavily and became atonic under general anaesthesia. Bleeding was profuse and could not be controlled by Ergometrine, Oxytocin or direct intramyometrial injection of Prostaglandins. The device 1 as described above was inserted and inflated quickly using saline to a volume of 200cc. The internal balloon 2 was checked for position and fit under ultrasound guidance. There was an immediate and dramatic reduction of bleeding and over the next two hours, the clinician was able to gradually deflate the internal balloon 2 and remove it. There was only minimal blood loss following this.
The internal balloon 2 is inserted into a blind cavity. In a paramedical situation there is not way to determine whether or not a balloon on its own is engaged with the wall of the uterus TJ with any degree of certainty. The external balloon 10 functions as a detector / regulator of this contact pressure.
The device 1 of the invention can be used for atonic uterus and thus it may prove to be a worthwhile and lifesaving device in countries where there is a high incidence of death from primary postpartum haemorrhage and where access to surgical facilities and pharmacology is poor.
The device 1 is simple and mobile, and can be used in the field. The device 1 is light and compact and requires no specialised equipment for operation. In particular the device 1 does not require an electrical power source to operate. As such the device 1 is particularly suitable for paramedical applications.
The invention is not limited to the embodiments hereinbefore described, with reference to the accompanying drawings, which may be varied in construction and detail.

Claims

1. A device for staunching postpartum haemorrhage comprising:- an internal balloon for insertion into a uterus; the internal balloon being inflatable to engage the wall of a uterus; a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid communication with an inflation source; the internal balloon being attached to the tubular conduit at a single attachment region to facilitate unconstrained inflation of the internal balloon; and a first indicator for indicating when the internal balloon has engaged the wall of a uterus.
2. A device as claimed in claim 1 wherein the device comprises a second indicator for indicating subsequent contraction of a uterus.
3. A device as claimed in claim 2 wherein the first indicator and the second indicator are provided by a single indicator device.
A device as claimed in any of claims 1 to 3 wherein the tubular conduit defines a longitudinal axis, and the internal balloon is inflatable in a direction parallel to the tubular conduit longitudinal axis.
5. A device as claimed in claim 4 wherein the internal balloon defines three mutually perpendicular co-ordinate axes, and the internal balloon is inflatable in directions parallel to all three co-ordinate axes.
6. A device as claimed in any of claims 1 to 5 wherein the internal balloon comprises an inlet, and the inlet of the internal balloon is attached to the single attachment region of the tubular conduit.
7. A device as claimed in claim 6 wherein the internal balloon comprises a continuous balloon wall with a single opening in the balloon wall, the single opening providing the inlet.
8. A device as claimed in any of claims 1 to 7 wherein an outer surface of the internal balloon is substantially smooth.
9. A device as claimed in any of claims 1 to 8 wherein the indicator is connected in fluid communication with the tubular conduit.
10. A device as claimed in claim 9 wherein the tubular conduit comprises an indicator port for connecting the indicator in fluid communication with the tubular conduit.
11. A device as claimed in claim 9 or 10 wherein the device comprises external valves means intermediate the tubular conduit and the indicator.
12. A device as claimed in any of claims 9 to 11 wherein the indicator is inflatable.
13. A device as claimed in claim 12 wherein the indicator comprises an external balloon.
14. A device as claimed in claim 13 wherein the internal balloon and the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
15. A device as claimed in claim 14 wherein the defined pressure is less than or equal to mean arterial pressure.
16. A device as claimed in claim 14 or 15 wherein the dimensions of the internal balloon and the dimensions of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
17. A device as claimed in claim 16 wherein: rι/tι > r2/t2 where: - Tt = radius of the internal balloon when in a static uninflated state. r2 = radius of the external balloon when in a static uninflated state, t] = wall thickness of the internal balloon when in a static uninflated state. t2 = wall thickness of the external balloon when in a static uninflated state.
18. A device as claimed in claim 17 wherein the ratio of rι tι : r2/t2 is at least 2:1.
19. A device as claimed in claim 18 wherein the ratio of rι/tι : r2/t2 is approximately 2.5:1.
20. A device as claimed in any of claims 16 to 19 wherein the volume of the internal balloon when in a static uninflated state is substantially larger than the volume of the external balloon when in a static uninflated state.
21. A device as claimed in claim 20 wherein the ratio of the volume of the internal balloon when in a static uninflated state to the volume of the external balloon when in a static uninflated state is at least 10:1.
22. A device as claimed in claim 21 wherein the ratio is at least 15:1.
23. A device as claimed in claim 22 wherein the ratio is approximately 17:1.
24. A device as claimed in any of claims 16 to 23 wherein the surface area of the internal balloon when in a static uninflated state is substantially larger than the surface area of the external balloon when in a static uninflated state.
25. A device as claimed in claim 24 wherein the ratio of the surface area of the internal balloon when in a static uninflated state to the surface area of the external balloon when in a static uninflated state is at least 5:1.
26. A device as claimed in claim 25 wherein the ratio is approximately 7:1.
27. A device as claimed in any of claims 14 to 26 wherein the material properties of the internal balloon and the material properties of the external balloon are configured to facilitate inflation of the internal balloon in the event of a defined fluid pressure within the internal balloon and to resist inflation of the external balloon in the event of the same defined fluid pressure within the external balloon.
28. A device as claimed in claim 27 wherein: -
Eι < E2 where: - Ε\ = modulus of elasticity of the internal balloon; E2 = modulus of elasticity of the external balloon;
29. A device as claimed in any of claims 1 to 28 wherein the device comprises a connector for attaching the internal balloon to the tubular conduit.
30. A device as claimed in claim 29 wherein the connector has a proximal region attached to an outer surface of the tubular conduit, and a distal region attached to an outer surface of the internal balloon.
31. A device as claimed in claim 30 wherein the distal region extends substantially tangentially around at least part of the outer surface of the internal balloon.
32. A device as claimed in claim 30 or 31 wherein the connector tapers outwardly from a proximal end of the connector to a distal end of the connector.
33. A device substantially as hereinbefore described with reference to the accompanying drawings.
34. A method of staunching postpartum haemorrhage comprising the steps of: - providing a device comprising an internal balloon, a tubular conduit having a distal end in fluid communication with the internal balloon and a proximal end in fluid connection with an inflation source, and a first indicator; inserting the internal balloon into a uterine cavity; inflating the internal balloon until the internal balloon engages the wall of the uterus; and monitoring the first indicator to determine when the internal balloon has engaged the wall of the uterus.
35. A method as claimed in claim 34 wherein engagement of the internal balloon with the wall of the uterus causes the first indicator to inflate.
36. A method as claimed in claim 35 wherein the first indicator is connected in fluid communication with the tubular conduit.
37. A method as claimed in any of claims 34 to 36 wherein the device comprises a second indicator, and the method comprises the step of monitoring the second indicator to determine subsequent contraction of the uterus.
38. A method as claimed in claim 37 wherein subsequent contraction of the uterus causes the second indicator to inflate.
39. A method as claimed in claim 38 wherein the second indicator is connected in fluid communication with the tubular conduit.
40. A method as claimed in any of claims 37 to 39 wherein the first indicator and the second indicator are provided by a single indicator device.
41. A method as claimed in any of claims 34 to 40 wherein the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, stopping inflation of the internal balloon.
42. A method as claimed in any of claims 34 to 40 wherein the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus.
43. A method as claimed in claim 42 wherein the method comprises the step of disconnecting the indicator from the tubular conduit before further inflating the internal balloon.
44. A method as claimed in any of claims 34 to 40 wherein the method comprises the step of, after engagement of the internal balloon with the wall of the uterus, further inflating the indicator.
45. A method as claimed in claim 44 wherein the method comprises the step of at least partially deflating the indicator to further inflate the internal balloon to increase contact pressure between the internal balloon and the wall of the uterus.
46. A method as claimed in claim 45 wherein the indicator is at least partially deflated by squeezing the indicator.
47. A method of staunching postpartum haemorrhage substantially as hereinbefore described with reference to the accompanying drawings.
PCT/IE2004/000133 2003-09-29 2004-09-29 A device for staunching postpartum haemorrhage WO2005030064A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/391,475 US20060173486A1 (en) 2004-09-29 2006-03-29 Device for staunching postpartum haemorrhage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50614203P 2003-09-29 2003-09-29
US60/506,142 2003-09-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/391,475 Continuation US20060173486A1 (en) 2004-09-29 2006-03-29 Device for staunching postpartum haemorrhage

Publications (1)

Publication Number Publication Date
WO2005030064A1 true WO2005030064A1 (en) 2005-04-07

Family

ID=34393119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE2004/000133 WO2005030064A1 (en) 2003-09-29 2004-09-29 A device for staunching postpartum haemorrhage

Country Status (2)

Country Link
WO (1) WO2005030064A1 (en)
ZA (1) ZA200602697B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080154284A1 (en) * 2005-02-08 2008-06-26 Rajiv Varma Device to Assist in Cesarean Section
CN102525590A (en) * 2010-12-10 2012-07-04 上海市第十人民医院 Intrauterine compression hemostasis method and device
US9055949B2 (en) 2007-02-09 2015-06-16 B & D Medical Development, Llc Balloon tamponade
US11090084B2 (en) 2017-11-16 2021-08-17 Safe Obstetric Systems Limited Fetus delivery assisting device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE419167C (en) * 1924-10-31 1925-09-21 Antonio Schibuola Dr Device for stopping bleeding of the uterus
DE1239432B (en) * 1964-06-29 1967-04-27 Hans Albrecht Alber Dr Med Device for exerting a contraction stimulus on the uterus
US4230119A (en) * 1978-12-01 1980-10-28 Medical Engineering Corp. Micro-hemostat
WO2003032847A1 (en) * 2001-10-17 2003-04-24 Atos Medical Ab A device for controlling bleeding and a method for producing the device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE419167C (en) * 1924-10-31 1925-09-21 Antonio Schibuola Dr Device for stopping bleeding of the uterus
DE1239432B (en) * 1964-06-29 1967-04-27 Hans Albrecht Alber Dr Med Device for exerting a contraction stimulus on the uterus
US4230119A (en) * 1978-12-01 1980-10-28 Medical Engineering Corp. Micro-hemostat
WO2003032847A1 (en) * 2001-10-17 2003-04-24 Atos Medical Ab A device for controlling bleeding and a method for producing the device

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080154284A1 (en) * 2005-02-08 2008-06-26 Rajiv Varma Device to Assist in Cesarean Section
US9055973B2 (en) * 2005-02-08 2015-06-16 Rajiv Varma Device to assist in cesarean section
US9055949B2 (en) 2007-02-09 2015-06-16 B & D Medical Development, Llc Balloon tamponade
US9888927B2 (en) 2007-02-09 2018-02-13 B & D Medical Development, Llc Balloon tamponade
CN102525590A (en) * 2010-12-10 2012-07-04 上海市第十人民医院 Intrauterine compression hemostasis method and device
US11090084B2 (en) 2017-11-16 2021-08-17 Safe Obstetric Systems Limited Fetus delivery assisting device

Also Published As

Publication number Publication date
ZA200602697B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
US20060173486A1 (en) Device for staunching postpartum haemorrhage
CA1213491A (en) Inflatable uterine hemostat
US9888927B2 (en) Balloon tamponade
CA2287474C (en) Device for the preparation and facilitation of giving birth and exercise method for preparing to give birth
JP2000515773A (en) Wound closure hemostasis device
US7909845B2 (en) Epistaxis apparatus and method
JP2022550659A (en) Abnormal uterine bleeding control system and method
JP2000515027A (en) Childbirth assistance equipment
KR101903591B1 (en) balloon catheter with hemostasis for vaginal bleeding
WO2005013834A1 (en) Tamponade balloon assembly
US3741216A (en) Cervical cuff
US20040127931A1 (en) Cervical dilator
JP6778255B2 (en) A device that protects the pelvic floor during vaginal delivery
ZA200602697B (en) A device for staunching postpartum haemorrhage
US20180000488A1 (en) Inflatable intrauterine balloon
CN111166416A (en) Lower uterine segment hemostasis structure for caesarean section
CN215349994U (en) Gynaecology and obstetrics&#39;s postoperative is with pressurization nursing area
IE20040663A1 (en) A device for staunching postpartum haemorrhage
KR20010002164A (en) A device to contract the uterus
US11090084B2 (en) Fetus delivery assisting device
CA2661353C (en) Epistaxis apparatus and method
AU2013204791B2 (en) Surgical vaginal support device for surgical treatment of pelvic organ prolapse
CN210813420U (en) Improved uterine dilator
CN214966431U (en) Obstetrical department uses hemostasis device
CN217938294U (en) Hemorrhoid compression hemostasis device providing observation visual field

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11391475

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 11391475

Country of ref document: US

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTIFICATION UNDER RULE 69(1) EPC DATED 04.08.2006.

122 Ep: pct application non-entry in european phase